BioCentury
ARTICLE | Finance

INKEF’s creative ambitions

Roel Bulthuis to ramp up company creation in the Netherlands via INKEF

December 4, 2018 5:22 PM UTC

With the appointment of Roel Bulthuis as managing director and head of the healthcare team, European VC INKEF Capital plans to take a more active role in healthcare company creation.

Bulthuis was previously managing director at M Ventures, the corporate venture fund of Merck KGaA (Xetra:MRK), where he led initial venture rounds for European healthcare companies including bispecific antibody company F-Star Biotechnology Ltd. and multiple sclerosis company Canbex Therapeutics Ltd. ...

BCIQ Company Profiles

INKEF Capital